Biotech Archives - Page 729 of 795

1 minute read

Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate

August 25, 2:45 PM

Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).

ESALF

8 minute read

Is Ibogaine A Safe And Effective Treatment For Addictions?

By El Planteo

August 25, 12:40 PM

By Santiago Federico Richetti via El Planteo.

NUMIF

1 minute read

Medtronic Recalls HeartWare HVAD System Batteries For Electrical Faults

By Vandana Singh

August 25, 12:38 PM

Medtronic Plc (NYSE:MDT) is recalling HeartWare HVAD System batteries because they may experience electrical faults that cause the system to fail…

MDT

2 minute read

SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report

By Vandana Singh

August 25, 12:36 PM

In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.

BVNKF

1 minute read

Pfizer’s COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows

By Vandana Singh

August 25, 12:29 PM

According to a new observational study published in the New England Journal of Medicine, Pfizer Inc's (NYSE: PFE) COVID-19 treatment, Paxlovid, only worked among patients 65 years of age or older, with

PFE

1 minute read

Dynavax’s Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations

By Vandana Singh

August 25, 10:31 AM

Hong Kong-listed Clover Biopharmaceuticals Ltd announced data from a global Phase 2/3 trial evaluating its COVID-19 vaccine candidate, SCB-2019, in adolescents (aged 12 to 17 years).

DVAX

1 minute read

Alaunos Therapeutics Shares UP 12%; Co On Wednesday Highlighted Acceptance For Presentation Titled ‘Objective clinical response by KRAS mutation-specific TCR-T cell therapy in previously treated advanced Non-small cell lung cancer’ On Sept. 30

By Benzinga Newsdesk

August 25, 10:23 AM

-SEC Filing

TCRT

1 minute read

With Sandoz Spinoff, Novartis Slams Brakes On Huntington’s Trial

By Vandana Singh

August 25, 10:12 AM

Novartis AG (NYSE: NVS) suspended dosing in a Huntington's disease study because early signs of side effects were seen in some participants in the trial.

NVS

1 minute read

FDA
News

FDA Says Medtronic Recalls Heartware HVAD System Batteries For Electrical Faults That Cause Battery Failure

By Benzinga Newsdesk

August 25, 9:57 AM

-Reuters

MDT

1 minute read

FDA Announced Clearance To Century Therapeutics’ Allogeneic Cell Therapy Candidate Study

By Ragothaman Srinivasan

August 25, 9:54 AM

Century Therapeutics, Inc. (NASDAQ: IPSC) received ELiPSE-1 clinical study may proceed notification from the U.S. Food and Drug Administration (FDA) to assess CNTY-101 in patients with relapsed or refractory CD19 positive B-cell malignancies.

IPSC